Cantel Medical acquires ConFirms sterilization monitoring business CANTEL MEDICAL CORP.

, through its Crosstex International subsidiary, has further expanded its infection avoidance and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc.0 million in GAAP sales, the privately-held business was founded 10 years ago and conducts over two million tests each year.5 million in cash at closing and contingent consideration of up to an additional $1.through January 31 0 million based on accomplishment of specified sales levels, 2012.Current traders, Atlas Venture, Novartis Venture Fund, SR One and SV Existence Sciences were became a member of by brand-new investor Astellas Venture Administration, the capital raising arm of Astellas Pharma. Bike's unique proprietary system technology, which generates a fresh modality of peptide therapeutics, has tremendous potential that may benefit the entire health care community. The ongoing firm can be applying the technology to drug discovery tasks in oncology, metabolic and inflammatory diseases and can make the platform available for collaborative discovery with pharma partners also. We are actually expanding our discovery initiatives to handle multiple drug focus on classes.